| Primary |
| Product Used For Unknown Indication |
57.2% |
| Non-small Cell Lung Cancer |
15.5% |
| Lung Neoplasm Malignant |
5.8% |
| Lung Carcinoma Cell Type Unspecified Stage 0 |
3.6% |
| Pancreatic Carcinoma |
3.4% |
| Adenocarcinoma Pancreas |
2.4% |
| Neoplasm Malignant |
2.4% |
| Oesophageal Squamous Cell Carcinoma |
2.2% |
| Pain |
1.3% |
| Non-small Cell Lung Cancer Metastatic |
1.0% |
| Hypertension |
0.9% |
| Prophylaxis |
0.7% |
| Nausea |
0.6% |
| Non-small Cell Lung Cancer Stage Iv |
0.6% |
| Lung Adenocarcinoma |
0.4% |
| Constipation |
0.4% |
| Rash |
0.4% |
| Diabetes Mellitus |
0.4% |
| Insomnia |
0.3% |
| Diarrhoea |
0.3% |
|
| Death |
51.6% |
| Rash |
8.2% |
| Malignant Neoplasm Progression |
7.5% |
| Off Label Use |
6.1% |
| Incorrect Dose Administered |
5.5% |
| Vomiting |
3.2% |
| Respiratory Failure |
2.8% |
| Weight Decreased |
2.5% |
| Pneumonia |
1.9% |
| Pulmonary Embolism |
1.3% |
| Urinary Tract Infection |
1.2% |
| Organ Failure |
1.1% |
| White Blood Cell Count Decreased |
1.1% |
| Stomatitis |
1.0% |
| Pleural Effusion |
0.9% |
| Pyrexia |
0.9% |
| Thrombocytopenia |
0.9% |
| Diarrhoea |
0.8% |
| Visual Impairment |
0.8% |
| Cardiac Failure |
0.7% |
|
| Secondary |
| Product Used For Unknown Indication |
63.9% |
| Non-small Cell Lung Cancer |
10.0% |
| Adenocarcinoma Pancreas |
7.0% |
| Lung Neoplasm Malignant |
2.8% |
| Lung Carcinoma Cell Type Unspecified Stage 0 |
2.2% |
| Pain |
1.8% |
| Pancreatic Carcinoma |
1.8% |
| Hypertension |
1.8% |
| Prophylaxis |
1.6% |
| Constipation |
0.9% |
| Lung Cancer Metastatic |
0.8% |
| Gastritis |
0.7% |
| Small Intestine Carcinoma |
0.7% |
| Insomnia |
0.6% |
| Lung Adenocarcinoma |
0.6% |
| Diarrhoea |
0.6% |
| Cough |
0.5% |
| Non-small Cell Lung Cancer Stage Iv |
0.5% |
| Diabetes Mellitus |
0.5% |
| Rash |
0.5% |
|
| Rash |
27.3% |
| Weight Decreased |
15.0% |
| Vomiting |
10.0% |
| White Blood Cell Count Decreased |
5.8% |
| Off Label Use |
5.4% |
| Stomatitis |
5.0% |
| Malignant Neoplasm Progression |
4.2% |
| Thrombocytopenia |
3.5% |
| Thrombosis |
3.1% |
| Rash Generalised |
2.3% |
| Respiratory Failure |
2.3% |
| Skin Disorder |
2.3% |
| Visual Impairment |
2.3% |
| Pneumonia |
1.9% |
| Transaminases Increased |
1.9% |
| Death |
1.5% |
| Nausea |
1.5% |
| Skin Infection |
1.5% |
| Subdural Haematoma |
1.5% |
| Sunburn |
1.5% |
|
| Interacting |
| Product Used For Unknown Indication |
66.7% |
| Squamous Cell Carcinoma |
22.2% |
| Lung Adenocarcinoma |
5.6% |
| Pancreatic Carcinoma |
5.6% |
|
| Swelling Face |
50.0% |
| Vomiting |
50.0% |
|
